Coronary Artery Plaque Burden in Stable Angina and Non-obstructive Coronary Artery Disease

Sponsor
University of Bergen (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04009421
Collaborator
Haukeland University Hospital (Other)
1,400
1
58.5
23.9

Study Details

Study Description

Brief Summary

Non-obstructive coronary artery disease (CAD), particularly common in women, has been associated with impaired quality of life and risk of recurrent hospitalizations. Several studies have also demonstrated increased risk of incident acute coronary events and mortality.

The main objective of the project is to assess the association between coronary artery plaque features by coronary CT angiography and long term prognosis in a large unselected population undergoing CT coronary angiography due to stable angina and suspected myocardial ischemia from the Norwegian Registry for Invasive Cardiology (NORIC) diagnosed with non-obstructive CAD by coronary CT angiography.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Coronary artery plaque assessment by CT coronary angiography QAngio CT RE

Detailed Description

Patients with stable angina and non-obstructive coronary artery disease by CT coronary angiography will be selected from the Norwegian Registry of Invasive Cardiology (NORIC). This is a national quality control registry run and controlled by the Norwegian Institute of Public Health (www.fhi.no). All CT coronary angiograms will be reanalyzed using advanced post-processing analysis software to assess coronary artery plaque burden, distribution and composition. Through linking with the Norwegian Cardiovascular Disease Registry and the Cause of Death Registry (www.fhi.no) we will be able to assess the association between long-term prognosis (5 years) and coronary artery plaque features.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
1400 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Covariates of Coronary Artery Plaque Burden and Composition by CT Coronary Angiography in Women and Men With Stable Angina and Non-obstructive Coronary Artery Disease - Analysis From the NORIC Registry
Actual Study Start Date :
Feb 15, 2018
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Jan 1, 2023

Arms and Interventions

Arm Intervention/Treatment
High and low coronary artery plaque burden

Patients with high plaque burden defined as plaque in >=4 segments of the coronary tree and low plaque burden as plaque in <4 segments of the coronary tree assessed by postprocessing of CT coronary angiography images and cardiovascular events and mortality.

Diagnostic Test: Coronary artery plaque assessment by CT coronary angiography QAngio CT RE
Assessment of segmental plaque volume and composition

Outcome Measures

Primary Outcome Measures

  1. Cardiovascular mortality and nonfatal acute myocardial infarction [5 years]

    Composite of deaths caused by cardiovascular disease and nonfatal acute myocardial infarction

Secondary Outcome Measures

  1. All-cause mortality, hospitalization due to cardiovascular disease and revascularization procedures [5 years]

    All-cause mortality, hospitalization due to cardiovascular disease and revascularization procedures

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Stable angina

  • Non-obstructive coronary artery disease by CT coronary angiography defined as <50% stenosis (lumen diameter reduction)

Exclusion Criteria:
  • Obstructive coronary artery disease

  • Unstable angina

  • Previous myocardial infarction, heart surgery or percutaneous coronary interventions

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Clinical Science, University of Bergen Bergen Norway 5021

Sponsors and Collaborators

  • University of Bergen
  • Haukeland University Hospital

Investigators

  • Principal Investigator: Mai Tone Lønnebakken, MD phd, University of Bergen

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mai Tone Lønnebakken, Professor, University of Bergen
ClinicalTrials.gov Identifier:
NCT04009421
Other Study ID Numbers:
  • 1573
First Posted:
Jul 5, 2019
Last Update Posted:
Jun 10, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mai Tone Lønnebakken, Professor, University of Bergen
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 10, 2022